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ABSTRACT 
 
A distal radius fracture (DRF) remains the most common fracture encountered in health care. 
DRFs have traditionally been treated with a plaster or surgically with percutaneous methods. 
Since the end of the 20th century, when internal fixation with a volar locking plate (VLP) was 
introduced, the incidence of DRF surgery in general and of plating in particular have increased 
markedly. The change in practice took place despite the lack of evidence of the superiority of 
VLPs over percutaneous methods for adult patients and over non-operative treatment for 
elderly patients. 
The aim of this thesis was to compare clinical outcome between treatment methods and to 
describe regional variation in surgical treatment of DRFs in Sweden. 
Study I was a descriptive study using registry data from 22 378 individuals in the Swedish 
national patient registry from 2010 to 2013. There was a large variation in surgical treatment 
regimens for DRFs among the 21 health care regions, not explained by age or gender. 
Proportions of internal fixation varied from 41% to 95%, pin fixation varied from 2% to 44% 
and external fixation (EF) varied from 1% to 19%. 
Study II and IV constituted a three-year follow-up of 118 and 113 patients respectively, 50-74 
years old with an unstable dorsally displaced DRF, from a previously published randomized 
controlled trial of 140 patients, allocated to VLP or EF. Patient-reported outcome measures 
(PROMs) as well as grip-strength, range of motion, occurrence of osteoarthritis and 
complication rates presented in Study II, were similar in both groups. The VLP group displayed 
a higher mean total cost and less gained quality of life adjusted life-years (QALYs) compared 
with the EF group, indicating in Study IV that VLP is not cost-effective in comparison to EF. 
Study III was a randomized controlled trial, allocating 140 patients, 70 years or older, with an 
unstable dorsally displaced DRF to VLP or non-operative treatment. At 12 months 119 patients 
were evaluated and PROMs, grip-strength, volar flexion and radiographs were significantly 
better for the VLP group. Complication rates were similar. 
In conclusion, surgical treatment regimens for DRFs vary widely among health care regions in 
Sweden and when comparing treatment outcomes; for elderly patients VLP fixation seems to 
yield superior clinical results compared with non-operative treatment, but for patients aged 50-
74 years, VLP fixation does not seem to yield superior clinical results and does not seem to be 
cost-effective as compared with EF in a three-year perspective. 
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2 INTRODUCTION 
 
2.1 EPIDEMIOLOGY 
A distal radius fracture (DRF) is the most common fracture to be treated in health care1. The 
incidence is high among children but declines when individuals reach the age of puberty2. For 
women it increases again from the age of 50 and for men from the age of 70, mainly due to 
osteopenia3,4 (Figure 1). Incidence for women and men over the age of 50 is 66-110 and 12-25 
per 10 000 person-years, respectively5. The total incidence increased from the 1950s6 but has 
decreased since the turn of the century4. 
 
Figure 1. Incidence rates for DRFs in Sweden from 2005 to 20103 
 
2.2 ETIOLOGY 
DRFs are caused by a combination of axial loading and bending forces through the carpus 
acting on the distal radius, commonly experienced when falling on an outstretched arm/hand.  
Among young adults, the mechanism of injury is often high energy trauma, whereas among 
elderly persons with osteopenia the fractures are most often caused by low-energy trauma, such 
as a fall from a standing or walking position7,8. 
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2.3 FRACTURE CLASSIFICATION 
DRFs are traditionally divided into three main types; isolated intraarticular fracture with the 
rest of the metaphysis intact, i.e. Barton’s fracture or Chauffeur’s fracture, metaphyseal fracture 
with volar angulation of the distal fragment, i.e. Smith fracture, and metaphyseal fracture with 
dorsal angulation of the distal fragment, i.e. Colles’ fracture, which constitutes the vast majority 
of all DRFs (Figure 2). 
 
Figure 2. Radiograph of a dorsally displaced DRF (Colles’ fracture), lateral and posteroanterior 
(PA) views 
 
There are several classification systems for DRFs. For Colles’ fractures, the Older 
classification9 is useful. It describes the degree of dorsal displacement of the distal fragment, 
the degree of radial shortening and the degree of comminution of the dorsal cortex close to the 
fracture, as predictors of fracture instability. A further development of the Older classification 
is the recently introduced Buttazoni classification10, which is simpler and includes 
comminution of the volar cortex as a predictor of instability. A commonly used classification 
is the universal AO/OTA system11 which describes three main types of fractures: (A) 
extraarticular, (B) partial intraarticular and (C) complete intraarticular, with subgroups within 
each main type. Another common classification is the Frykman classification12, which divides 
the DRFs into intra- or extraarticular fractures, with or without a concomitant fracture of the 
distal ulnae. The Fernandez classification13, which is based on the mechanisms of the injury, 
ranging from bending, shearing, compression, avulsion/fracture dislocation to combined/high 
velocity injury is also commonly used. However, all classification systems have more or less 
low intra- and interobserver reliability10,14,15, which makes it difficult to choose a treatment 
strategy based on the fracture classifications. 
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2.4 TREATMENT METHODS 
2.4.1 Non-operative treatment 
Treatment with a cast or a splint is the oldest and most common treatment method16. It is 
applied dorso-radially from the distal third of the metacarpal bones to the proximal forearm 
and is maintained for four to five weeks. The method has few complications (limited to 
pressure/wounds from the cast/splint). If the fracture is displaced, casting is preceded by closed 
reduction under local, regional or general anaesthesia. For most fractures, non-operative 
treatment is sufficient16-18, but for unstable fractures a cast alone cannot prevent fracture re-
displacement before healing, which renders malunion19. 
In general, a malunited fracture results in an inferior clinical outcome20,21. However, there are 
controversies whether this correlation exists for elderly patients22-29. 
A fracture is considered unstable if it cannot be maintained in an adequate position in a cast 
until healing. Factors predicting DRF instability are high age, high degree of initial 
displacement and comminution of the cortex at the fracture site19,30-34. 
2.4.2 Surgical treatment 
Surgical treatment aims to reduce unstable fractures and retain them in an adequate position 
until healing, thereby preventing malunion.  
2.4.2.1 Pin fixation (PF) 
During the 1960s, PF was introduced. It is a method where metal pins are inserted into the 
fractured bones to reduce and fix the fracture fragments35 (Figure 3). Usually a cast is used as 
a complement to add further stability36. The cast and the pins are removed when the fracture is 
healed. This method have been proven to yield good results, but may have worse outcomes in 
older patients with osteopenic bone, in which the pins can lose the grip and thereby be unable 
to retain the fracture reduction until healing occurs37. Pins can also be used as a complement to 
other surgical treatment methods. Common complications to pinning are soft tissue infections 
at pin sites38 and damage to nerves or tendons when inserting the pins39. 
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Figure 3. Radiograph after pin fixation of a DRF, PA view 
 
2.4.2.2 External fixation (EF) 
Treatment with EF, a metal construction worn outside the arm and attached to the bone on each 
side of the fracture via pins through the skin, was introduced during the 1970s40,41 (Figure 4). 
Two threaded pins are inserted into the diaphysis of the radius, via either stab incisions or a 
longer dorsolateral incision, and two pins are inserted into the second metacarpal bone of the 
hand via stab incisions. Under fluoroscopic control, traction is then applied over the wrist and 
the fracture is reduced as the traction force is transferred to the distal fragment through 
ligamentotaxis42,43. Traction is maintained by a metal rod attached to the pins by metal blocks. 
The EF device is subsequently removed after five to six weeks, usually at an outpatient clinic 
visit. EF is a simple and fast surgical method. Percutaneous pinning can be used to further add 
stability to the construct44,45. A common complication is soft tissue infection at the pin sites46,47, 
which sometimes needs treatment by oral antibiotics. Daily cleaning of the pin sites is 
recommended to reduce the risk of infection42. Injury to the cutaneous branch of the radial 
nerve can occur when inserting the proximal pins into the forearm46. This can be avoided by 
doing larger incisions so that nerves can be identified and respected. Due to elongation of the 
radiocarpal ligaments and capsule, loss of reduction can occur during the fixation time48,49. The 
treatment method can be perceived as negative by the patient due to the bulky construct of the 
EF device, and because movement of the wrist joint during the fixation time is prevented. 
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Figure 4. External fixation of a DRF (Copyright: Cecilia Mellstrand Navarro) 
 
2.4.2.3 Internal fixation (IF) with a dorsal plate 
During the 1990s, the method of using open reduction and IF with screws through a dorsally 
applied plate close to the bone was introduced31,50,51. The plate prevents dorsal displacement of 
the distal fragment but can often, due to the tight anatomy on the dorsal aspect of the wrist, 
cause extensor tendon synovitis and/or rupture50,51. An advantage of this method is the 
possibility of early motion of the wrist, which is considered favourable for rehabilitation. 
However, plating requires superior surgical skills compared with percutaneous methods. 
2.4.2.4 IF with a volar locking plate (VLP) 
At the end of the 20th century, plates with angle stable screws were introduced52, and they have 
provided good clinical and radiological results53-55. The construct enables volar placement of 
the plate, which reduces the tendon attrition problems associated with the dorsal plate56,57, 
without the risk of loosening the screws and plate when the dorsal displacement forces on the 
distal fragment exceeds the screw attachment in the bone58. The skin incision is made over the 
flexor carpi radialis tendon and the flexor tendons, the median nerve and the radial artery are 
held aside with retractors. The pronator quadratus muscle is detached from its radial attachment 
and the plate is placed under the muscle on the volar aspect of the radial bone (Figure 5). 
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Figure 5. Volar locking plate during surgery of a DRF (Copyright: Cecilia Mellstrand Navarro) 
  
Volar, as well as dorsal, plating requires superior surgical skills compared with percutaneous 
methods. The strength of the angle stable construction requires a subchondral placement of the 
distal row of the screws59 (Figure 6). Too proximal a placement of the plate and the screws can 
lead to a loss of the entire construct from the bone and subsequent fracture displacement60. 
Improper placement of the plate or inadequate fracture reduction can cause damage or irritation 
to tendons and/or nerves due to impingement caused by the plate61. Screws that are too long 
and protrude on the dorsal aspect of the radial bone can impact extensor tendons and cause 
tenosynovitis, or even tendon rupture62.  
Thus, common complications are tenosynovitis and symptoms from the median nerve due to 
the plate and screws39,63, and plate extraction is performed in 15-30% of the patients64-66.  
 
Figure 6. Radiographs after volar locking plate fixation of a DRF, lateral and PA views 
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2.4.3 General complications 
Complex regional pain syndrome (CRPS) is a condition that presents with abnormal pain, 
swelling, hyper-sensibility, increased or decreased hydration and/or skin temperature after an 
injury12. The pathogenesis is unclear. The risk of CRPS in the hand after a DRF is reduced by 
short surgical time, restricted use of a tourniquet, sufficient pain relief and accurate 
occupational therapy67. 
Carpal tunnel syndrome (CTS) is caused by impingement of the median nerve by sharp fracture 
edges, callus formation, hematoma or a volar plate. The risk is reduced by adequate fracture 
reduction/retainment and adequate placement of an eventual volar plate. 
Rupture of the extensor pollicis longus tendon in the third dorsal tendon compartment can occur 
even after a non-displaced DRF68. The pathogenesis is unclear.  
2.4.4 Treatment decisions 
There has been a shift in surgical treatment choices over the last 15 years, in Sweden3,4 as well 
as in other countries69-71, from predominantly percutaneous methods to IF with a volar plate. 
This shift has taken place despite the lack of evidence for the superiority of plate fixation versus 
EF or PF. In a meta-analysis from 2005 based on 46 studies, the authors concluded that there 
was no evidence that VLP was better than EF for unstable DRFs regarding functional 
outcome72. Since then, many studies have been conducted that compared VLP with EF or PF. 
The results are diverse, and there is still no consensus regarding which method renders the best 
functional outcome73-76. However, many studies imply that there is an advantage for VLP in 
the early recovery period, up to three months, but not thereafter74,77.  
The total rate of complications is similar for the different surgical methods, but for 
percutaneous methods they generally occur early, such as fracture displacement requiring IF 
or minor complications such as pin site infections, whilst VLPs render more late secondary 
surgeries, such as plate extractions and tendon reconstructions74,78-81. 
Few studies compare results beyond one year after surgery. Since VLPs seem to be associated 
with secondary surgeries up to seven years after primary surgery, long term results are of 
value79-83. 
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2.5 MEASURING OUTCOMES 
2.5.1 Objective measures 
2.5.1.1 Range of motion (ROM) 
ROM of the wrist is measured as degrees of dorsal extension, volar flexion, pronation, 
supination, radial deviation and ulnar deviation. There is a variation in ROM with respect to 
gender and age84 and it can therefore be measured as a percentage of the contralateral side. 
Most normal activities do not require full ROM85. 
2.5.1.2 Grip strength  
Grip strength is measured in kilograms or kilopascals, using a Martin vigorimeter (a ball) or a 
Jamar dynamometer (two handles). It is often reported as the mean of three attempts with 
maximal force. Grip strength varies with gender and age and it can therefore be expressed as a 
percentage of the contralateral side86. Both instruments are valid for pathologic conditions of 
the wrist87. A Martin vigorimeter is easier for elderly bedridden patients to use88. The minimal 
clinically important difference (MCID) is considered to be 19.5% of the contralateral side, or 
six kilograms89. In right-handed people the dominant hand is considered 10% stronger than the 
non-dominant hand, but in left-handed people both hands are considered equally strong90. 
2.5.1.3 Radiographs 
Standard projections are PA and lateral. In the PA projection, the length of the radius is 
measured at its ulnar corner in relation to the distal end of the ulna at its radial corner. The 
radial length is normally -1 to +2 mm in relation to the ulna. When a fracture of the distal radius 
occurs, there is normally a shortening of the radius, which is measured in millimetres. The 
inclination of the articular surface of the radius in relation to the perpendicular plane of the 
vertical axis of the radius is also measured. It is normally 19-24 degrees91 and it often decreases 
when a fracture occurs. In the lateral projection, the articular surface of the radius in relation to 
the perpendicular plane of the vertical axis of the radius is measured. It normally has a volar 
angle of 10-12 degrees. In a Colles’ fracture, a dorsal angulation occurs. A Colles’ fracture is 
considered minimally displaced if the radius is shortened less than three mm and the dorsal 
angulation is less than 15 degrees92. Posttraumatic osteoarthritis (OA) in the radiocarpal joint 
can be measured and graded according to Knirk and Jupiter93 on a scale of 0-3, where 0 is no 
loss of joint space, and 3 is a total loss of joint space. 
2.5.2 Patient-reported outcome measures (PROMs) 
For conditions in the musculoskeletal system, PROMs are suitable for measuring pain and 
functional impairment in daily life. 
2.5.2.1 Organ-specific protocols 
The Patient-Rated Wrist Evaluation (PRWE) score is a protocol designed and validated for 
wrist fractures94,95, which is also translated to and validated in Swedish96. Five questions 
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regarding pain and ten questions regarding function in daily life are answered on a scale of 0-
10 points, where 0 represents no pain/discomfort and 10 represents maximum pain/discomfort. 
The sum of the questions regarding function is divided by two and is then added to the sum of 
the questions regarding pain. The total score ranges from 0-100 points, where 0 represents no 
pain/discomfort in daily life. The MCID is considered to be 6-14 points97,98. 
The Disabilities of the Arm, Shoulder and Hand (DASH) score is a protocol designed and 
validated for measuring function in the upper extremity99. It has been translated to and validated 
in Swedish100. It consists of 30 questions on a scale of 1-5 regarding daily activities, where 1 
represents no disabilities. Thirty is subtracted from the total sum, and the remaining sum is then 
divided by 1.2. The total score ranges from 0-100 points and 0 represents no disabilities/no 
pain in daily life. The MCID is considered to be 10 points101. 
The Green O´Brien score102 was often used before the introduction of DASH and PRWE. It 
combines patient-reported pain and disabilities during daily activities with radiographs and 
ROM and renders a result within a four-grade score (excellent – good – fair – poor). 
There are also several other commonly used outcome protocols, for example the Gartland and 
Werely score103, the Mayo wrist score and the Michigan hand outcome score, but they are not 
reliable and valid for DRFs104. 
2.5.2.2 Health-related quality of life (HRQoL)instruments 
To compare a broad spectrum of injuries and conditions, HRQoL-instruments are used as 
complements to organ-specific protocols. 
The EuroQol 5 Dimensions (EQ-5D) index score is such an instrument105,106. It consists of five 
questions where the responders classify their disabilities regarding mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression at three levels; no problem, some problems 
or major problems. The combination of the answers leads to a five-digit health profile which is 
converted into a utility score using tariff values from a standard UK population107. A value of 
0.00 indicates the worst possible state of health, and a value of 1.00 indicates the best possible 
state of health. The score is translated into Swedish and is valid for DRFs108. The MCID is 
considered to be 0.074 units109. 
The EQ-5D index score can be used as an HRQoL component when calculating quality-
adjusted life years (QALYs), a measure used in cost-effectiveness analyses of healthcare 
treatments. QALYs constitute a composite of a state of HRQoL and the time in years spent in 
the state110. Thus, one QALY represents one year of perfect health. 
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2.6 ELDERLY PATIENTS 
For elderly patients, the incidence of volar plating has increased to the detriment of non-
operative treatment111. When a person becomes elderly is not clearly defined but a commonly 
accepted age is 65 years112. At that age many people retire and the demands on function 
decreases.  
The association between a malunited DRF and an impaired function has not been proven in 
elderly patients, as it has been in younger patients22-29. 
Surgical treatment of unstable fractures among the elderly has not proven superior to non-
operative treatment regarding functional outcome64,113-116. However, among an active and 
slightly younger population (61-80 years), one study has shown a better functional outcome 
after volar plating compared with non-surgical treatment117. Today’s elderly individuals live a 
more active life than in the past, and up-to-date trials designed for this population are largely 
lacking. 
Age is the single strongest predictor for instability in a DRF118, and unstable fractures among 
elderly patients tend to displace beyond the first two weeks19. Therefore, a radiologic 
examination up to two weeks to detect instability is not useful for elderly patients. In addition, 
for the oldest patients, closed reduction is of limited benefit as the fractures often re-displace 
to the initial position before healing119. 
 
2.7 HEALTH ECONOMIC ASPECTS 
In a setting with limited healthcare resources it is valuable to investigate health economic 
aspects of different treatment options. Because of the high incidence of DRFs and a growing 
preference for surgical treatments, in combination with the lack of evidence of the superiority 
of either surgical treatment method, there is a strong incentive to perform health economic 
evaluations of treatment options. 
American studies based on costs for insurance reimbursements found that costs were twice as 
high for EF and almost three times as high for VLP, compared with non-operative treatment120-
122.  
British studies have shown that VLP treatment is not cost-effective compared with PF up to 
one year after treatment of a DRF123,124.  
To the best of our knowledge, health economic assessments of surgery with VLP compared 
with EF for DRFs are lacking, and no study has investigated the cost-effectiveness of DRF 
surgery beyond a one-year perspective.  
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2.8 REGIONAL VARIATION 
Studies in the US69,125,126 and in the Netherlands127 found large regional variation in the 
incidence of treatment methods for DRFs. After adjusting for factors that possibly influence 
the choice of surgical method, such as proportion of hand surgeons, academic level of the clinic, 
age, gender and race, the region remained as a strong predictor for the choice of treatment125. 
Regional differences regarding treatment of ankle fractures, for which a consensus for 
treatment is also lacking, displayed the same pattern128. Furthermore, for hip fractures for which 
there is a convincing consensus, regional differences have been reported to be small129. 
Possible explanations for these variations are: a large interest in novel techniques, access to 
subspecialists, local traditions and personal preferences of the surgeon129. 
Within areas where cost-effectiveness differs markedly among the different treatment options, 
there are good reasons to discourage regional variations by establishing clear guidelines and 
presenting information to patients and professionals130. 
As there are indications that VLP is not cost-effective compared with percutaneous methods120-
122,124, and as health care resources are limited, there is a need to investigate regional differences 
in Sweden and similar countries regarding surgical treatment of DRFs. 
 
2.9 SWEDISH NATIONAL HEALTHCARE REGISTERS 
The unique Swedish personal identification number (PIN) was introduced in 1947 and is used 
in all healthcare registers and all patient records.  
The Swedish National Patient Register (NPR), maintained by the National Board of Health and 
Welfare, contains all inpatient and outpatient care, excluding primary healthcare. Data include 
patient data (PIN, gender, place of residence), caregiver’s data (a code from which department, 
hospital, city and healthcare region can be derived), date of admission and discharge, and 
medical data including diagnoses according to the 10th version of the International 
Classification of Diseases (ICD) and surgical procedures according to the Nordic Medico-
Statistical Committee (NOMESCO) Classification of Surgical Procedures131. The accuracy of 
the data in the NPR has been approximated to be 90%132. 
The Swedish Prescribed Drug Register (PDR)133, maintained by the National Board of Health 
and Welfare, includes information on all drug prescriptions. Data include patient data (PIN), 
drug data (name of drug and type of drug (a generic code), dose, quantity and number of daily 
defined doses (DDD)) and prescriber data. 
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3 AIMS OF THE THESIS 
 
The overall aim of this thesis was to compare outcomes between treatment methods and to 
describe regional variation in surgical treatment of DRFs in Sweden. 
 
The specific aims of the individual studies were as follows: 
Study I: To determine if the choice of surgical methods for treatment of DRFs differs among 
health care regions in Sweden. 
Study II: To compare VLP fixation with EF three years after surgical treatment of patients 
aged 50-74 years with an unstable dorsally displaced DRF. 
Study III: To compare VLP fixation with non-operative treatment in patients aged 70 years or 
older with an unstable dorsally displaced DRF. 
Study IV: To assess the cost-effectiveness of VLP fixation compared with EF three years after 
surgical treatment of patients aged 50-74 years with an unstable dorsally displaced DRF. 
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4 PATIENTS AND METHODS 
 
4.1 STUDY I 
This was a registry study based on records from the NPR. All adult patients recorded with a 
DRF and a simultaneous code for surgical fracture treatment of the hand or forearm from 2010 
to 2013 were included. Register variables included gender, age, type of surgical procedure and 
geographic location for the treatment according to the unique code for each of the 21 healthcare 
regions in Sweden.  
Treatments were divided into four groups: IF (volar, radial, dorsal or combined plating), PF, 
EF or other treatments or combinations of methods (Other). 
The total number and proportion (number in each group divided by the total number of 
operations) for each surgical treatment group was calculated for all regions together, and for 
each region separately.  
Incidence rates were calculated as the number of surgeries divided by the population in each 
region each year on November 1st according to Statistics Sweden (SCB) (www.scb.se). 
 
4.2 STUDY II 
4.2.1 Patients 
This was a three-year follow-up of a previously published randomized controlled trial80 in 
which patients treated at Södersjukhuset Hospital, Stockholm, Sweden, from September 2009 
to February 2013 for a DRF were included.  
Inclusion criteria were 50-74 years of age for women and 60-74 years for men, fall from a 
standing height, wrist radiographs with >20 degrees of dorsal angulation in the lateral view 
and/or >5 mm of radial shortening in the PA view, fracture diagnosed within 72 hours of injury, 
adequate knowledge of written and spoken Swedish language and residency within the 
catchment area of the hospital. Exclusion criteria were former disability of either wrist, severe 
joint disorder, concomitant injuries, cognitive dysfunction (Pfeiffer134 score <5), drug or 
alcohol abuse, psychiatric disorder, dependency in activities of daily life or a medical disorder 
preventing use of general anaesthesia. 
4.2.2 Interventions 
One hundred and forty patients were, after giving written consent, allocated to either VLP 
fixation (n = 70) or EF with or without additional pinning (n = 70). At the end-point after one 
year, 134 patients (EF n = 65, VLP n = 69) remained in the study. The early results have been 
reported previously and displayed no relevant differences after six weeks up to one year80.  
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Before three years from surgery had passed, these 134 patients were contacted by telephone or 
mail and asked to participate in a three-year follow-up study. 
4.2.3 Outcome measures 
DASH score was the primary outcome. PRWE score, EQ-5D index score, grip strength, ROM, 
radiological signs of OA and complications were secondary outcomes. An occupational 
therapist investigated grip strength (using a Martin vigorimeter) and ROM in the injured and 
uninjured extremity and results were presented as percentage of the uninjured side. A 
radiologist investigated radiographs for signs of OA. For detection of complications, patients 
were examined and interviewed, and patient records were reviewed. Any complication 
remaining at the three-year follow-up and all reoperations (except for removal of the external 
fixator) were reported. 
 
4.3 STUDY III 
4.3.1 Patients 
The study was a fusion of two separate prospective randomized controlled studies at 
Södersjukhuset Hospital (SH) and Danderyd Hospital (DH) in Stockholm, Sweden. The study 
population consisted of patients aged 70 years or older admitted to SH from April 2013 to 
February 2017 (n = 76) or to DH from December 2009 to January 2017 (n = 64), with an 
unstable dorsally displaced DRF. The studies were fused in December 2016 to reach the 
estimated sample size in an acceptable time period. Inclusion and exclusion criteria are 
presented in Table 1.  
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Table 1. Inclusion and exclusion criteria in a randomized controlled study comparing non-
operative treatment with VLP fixation in patients 70 years or older, with a dorsally displaced 
DRF. 
Inclusion criteria 
• Patient age ≥75 years (from September 2015 ≥70 years at SH*) 
• Wrist radiography with ≥20 degrees dorsal tilt (and/or ≥4 mm axial shortening at 
DH**) 
Exclusion criteria 
• Former disability of either wrist 
• High-energy trauma (SH*) 
• Associated ulna fracture proximal to the ulnar styloid 
• Injury to the ipsilateral upper extremity  
• Rheumatoid arthritis or other severe joint disorder  
• Dementia or Pfeiffer score <5 at SH* and <8 at DH** 
• Drug/alcohol abuse or psychiatric disorder 
• Dependency in activities of daily living 
• Patient not resident within the catchment area of the two centres 
• Fracture diagnosed >3 days from injury at SH* and >6 days at DH** 
• Patient not fit for surgery/ASA class 4 
 
*Sodersjukhuset Hospital 
**Danderyd Hospital 
 
4.3.2 Interventions 
All patients underwent closed reduction and immobilization in a dorsal or dorsoradial short-
arm plaster splint in the emergency room. After written consent, patients were randomized to 
surgical treatment with a VLP or to non-operative treatment with continuation in the plaster 
splint. Surgery with VLP was performed within 14 days of the fracture date with a standard 
volar Henry’s approach under fluoroscopic control. The wrist was then immobilized in a dorsal 
plaster splint for two weeks. For the non-operative treatment group, the plaster splint from the 
emergency department was maintained for four to five weeks. Thereafter all patients were 
referred to an occupational therapist. Follow-up took place at four to five weeks, three months 
and one year after initial treatment. At DH the three-month follow-up ceased in November 
2011. Therefore, data were available for only 93 patients at three months. 
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4.3.3 Outcome measures 
PRWE score was the primary outcome at SH and a secondary outcome at DH. DASH score 
was the primary outcome at DH and a secondary outcome at SH. Other secondary outcomes at 
both sites were EQ-5D index score, grip strength, ROM, radiological parameters and 
complications. Grip strength and ROM were evaluated by an occupational therapist at each 
site. A 10% adjustment for hand dominance was performed for right-handed individuals as 
suggested by Crosby et al90. All radiographs were evaluated by a radiologist at DH. Patients 
were interviewed and examined for complications and patients’ records were reviewed. Life-
threatening events or complications requiring surgical intervention were considered major 
complications. All other complications were considered minor. 
 
4.4 STUDY IV 
4.4.1 Patients 
This study was a cost-effectiveness analysis based on the same patient cohort as in Study II. Of 
the 140 patients, 50-74 years old, with an unstable dorsally displaced DRF randomized to VLP 
or EF, 118 were available three years after the surgery. 
4.4.2 Methods 
The primary outcome was the incremental cost effectiveness ratio (ICER) for VLP compared 
with EF. The ICER was defined as the difference in mean total cost per patient divided by the 
difference in mean QALY per patient, expressed as the incremental cost per gained year of 
full health for VLP compared with EF. If the mean difference in total cost was positive and 
the mean difference in QALYs was negative (i.e. VLP cost more but gained less QALYs), 
no ICER was calculated, as VLP was then dominated by EF. If the mean difference in total 
cost was negative and the mean difference in QALYs was positive, no ICER was 
calculated, as VLP was then dominating EF. 
Total cost per patient was calculated by combining resource use with resource unit costs and 
summing up indirect costs (i.e. sick leave) and direct costs (all other costs) up to one and three 
years after surgery, respectively. Only participants with complete data were analysed. 
4.4.2.1 Resource use 
All resources needed for each treatment method were identified by the research group. 
Resource use data of surgical time for the primary surgery were derived from prospectively 
inserted data in the surgery software system (Orbit) used at SH. Inpatient and outpatient visits 
were retrieved from the NPR. Drug usage (number of DDDs prescribed for antibiotics and 
analgesics) was collected from the PDR. Data regarding sick leave were collected from the 
Swedish Social Insurance Agency. Any reoperations were detected by searches of patient 
records and/or registry data from the NPR regarding surgical procedures related to any possible 
related complication. Estimations of resource use were performed by the study group for 
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occupational therapy and X-rays since no complete registry or study protocol source was 
available. The time frame for all resource use was set from the date of the injury to the date for 
the three-year follow-up.  
4.4.2.2 Unit costs 
Unit costs for the operating theatre, including staff, were derived from the Swedish Agency for 
Health Technology Assessment and Assessment of Social Services (SBU)135. Costs regarding 
in- and outpatient care including emergency ward visits were collected from the diagnosis-
related group (DRG) financial reimbursement system used at SH. Costs for drug usage were 
calculated from prices defined in Pharmaceutical Specialities in Sweden (FASS), a compilation 
from the pharmaceutical industry with information about drugs used in Sweden, for one DDD 
as defined in the PDR. Unit costs for reoperations were calculated based on the study group’s 
opinion regarding surgical time and material usage. The unit cost regarding production loss per 
day (sick leave) was derived from SCB, using the mean income for adults 20-74 years of age 
plus taxes and social service fees. All costs were presented in euros converted from Swedish 
krona (SEK) using an exchange rate of 0.0978.  
4.4.2.3 Effectiveness 
Effectiveness of treatment was defined as QALYs as calculated from prospectively collected 
data of EQ-5D index score reported by trial participants at baseline and at two weeks, six 
weeks, three months, one year and three years postoperatively. Individual QALYs for each 
time interval were calculated by taking the average EQ-5D index score at two adjacent time 
points multiplied with the time in years spent in each time interval. Total QALYs gained at one 
and three years were then calculated on an individual level using the area under the curve 
approach. In clinical trials EQ-5D index score at baseline is invariably imbalanced between 
trial arms even if not statistically significant. In cost-effectiveness analyses the difference needs 
to be adjusted for, as it will be conducted throughout the entire follow-up period and contribute 
to QALYs not as an effect of treatment136. Therefore, the difference in mean QALYs between 
VLP and EF was adjusted for EQ-5D index score at baseline. 
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5 STATISTICAL METHODS 
 
Data in all studies were analysed using SPSS version 23 or 24 (IBM, Armonk, NY USA). 
5.1 STUDY I 
As the study population consisted of the entire Swedish population (a descriptive study), no p-
values or confidence intervals were needed for proportions of surgical treatments. 
Nevertheless, a multinomial logistic regression was performed controlling for age over 60 years 
and gender, choosing the region using IF most frequently as the reference. Significance was set 
at p < 0.05 in two-sided tests.  
5.2 STUDIES II-IV 
Normality was tested with the Shapiro-Wilks test for numerical variables. Student’s t-test was 
used for normally distributed variables, and Mann-Whitney U test for variables with skewed 
distributions. Chi-square test or Fisher’s exact test was used for comparisons of categorical 
variables. The level of significance was set at p < 0.05 in two-sided tests. In Study II linear 
regression was performed to detect any correlation between radiographic signs of OA and 
inferior DASH score. 
In Study IV, multiple linear regression was used to adjust the mean difference in QALYs at 
one and three years for imbalance between groups in EQ-5D index score at baseline136. Non-
parametric bootstrapping137 was used to determine the level of sampling uncertainty around the 
ICER. The bootstrap was performed as a resampling from the original sample, with 
replacement of each individual picked, to select 58 individuals from the VLP group and 55 
individuals from the EF group in each sample (i.e. one individual could be picked several times 
in each sample). To adjust for baseline differences in EQ-5D index scores between groups136, 
we calculated the adjusted differential QALYs (VLP = intervention, EF = control) in each 
sample. One thousand samples where generated, rendering 1 000 estimates of mean 
incremental cost and effect pairs. The bootstrap was presented on an incremental cost-
effectiveness plane137. This illustrated the uncertainty surrounding the estimates of expected 
incremental costs and QALYs associated with VLP compared with EF. From the bootstrap 
cost-effectiveness acceptability curves (CEACs) were derived to summarize the uncertainty in 
the scatterplots, i.e. express the probability that VLP is cost-effective in comparison with EF 
for a range of thresholds for willingness to pay (WTP) per gained QALY137. A threshold of 
35 000 euros was chosen as the maximum WTP per gained QALY, which approximates the 
30 000 UK pounds sterling, considered a threshold for DRF treatment recommended by the 
National Institute for Health and Clinical Excellence (NICE) in Great Britain138. 
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6 RESULTS 
 
6.1 STUDY I 
 A total of 22 378 individuals were identified with a surgically treated DRF from 1 January 
2010 to 31 December 2013. The proportions of surgical methods were: IF 72%, PF 15%, EF 
10% and Other 3%. Among the 21 health care regions, the incidence rate of surgical treatment 
varied from 4.2 to 9.2 per 10 000 person-years. The proportion of IF varied from 41% to 95%, 
PF varied from 2.3% to 44% and EF varied from 0.6 to 19%. Differences were significant in 
all but six comparisons when controlled for gender and age. The regions with the highest IF 
frequencies were situated in the south of Sweden and regions reporting the lowest IF 
frequencies were, mainly situated in the northern parts of Sweden (Figure 7). 
 
Figure 7. Proportions of internal fixation in surgically treated DRFs for each health care region 
in Sweden from 2010 to 2013 
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6.2 STUDY II 
Of the 134 patients available for the one-year follow-up, 118 agreed to participate in the three-
year follow-up (EF n = 56, VLP n = 62) and completed the PROM questionnaires. Three 
patients in each group did not take part in the clinical and radiological evaluations.  
There were no clinically or statistically significant differences in PROMs, grip strength or 
ROM between groups (Table 2).  
 
Table 2. Clinical results in patients aged 50-74 years, treated for an unstable dorsally 
displaced DRF with EF or VLP, available at the three-year follow-up 
 EF (n=56) VLP (n=62) Mean 
Difference 
95% CI 
Mean DASH (SD) 7.0 (9.9) 5.4 (7.1) 1.6 -1.6 to 4.8 
Mean PRWE (SD) 6.6 (12.0) 6.1 (9.2) 0.5 -3.4 to 4.4 
Mean EQ-5D (SD) 0.92 (0.13) 0.92 (0.13) 0.00 -0.04 to 0.05 
Mean grip strength as % 
of uninjured wrist (SD) 
90 (16) 102 (59) 12 -4.5 to 28.7 
Mean dorsal extension as 
% of uninjured wrist (SD) 
94 (12) 97 (14) 3 -2.5 to 7.5 
Mean volar flexion as % 
of uninjured wrist (SD) 
89 (10) 93 (14) 4 -1.0 to 8.5 
Mean radial deviation as 
% of uninjured wrist (SD) 
94 (11) 100 (13) 6 0.9 to 10.0 
Mean ulnar deviation as 
% of uninjured wrist (SD) 
102 (15) 99 (13) 3 -2.6 to 7.9 
Mean supination as % of 
uninjured wrist (SD) 
96 (8) 95 (11) 1 -3.0 to 4.0 
Mean pronation as % of 
uninjured wrist (SD) 
100 (8) 99 (7) 1 -1.6 to 4.1 
SD = Standard Deviation 
 
There were radiographic signs of OA in 28% (15/53) of the EF patients and in 42% (25/59) of 
the VLP patients. There was no correlation between signs of OA and inferior DASH score. 
Reoperations were performed in 14% (8/56) of the EF patients and in 21% (13/62) of the VLP 
patients. The plate was removed in 11 of 62 patients in the VLP group. Five of these occurred 
later than one year after primary surgery. In the EF group, scar adherence was present in 60% 
(32/53) of the patients compared with 8% (5/59) in the VLP group, and minor nerve symptoms 
in 8% (4/53) of EF patients compared with 3% (2/59) in the VLP patients. The differences in 
signs of OA and complications were not statistically significant. 
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6.3 STUDY III 
One hundred and forty patients were included in the study (VLP n = 68, non-operative n = 72). 
At three months 122 patients were still in the study (VLP n = 58, non-operative n = 64) and at 
one year 119 patients remained (VLP n = 56, non-operative n = 63). In the non-operatively 
treated group, there were 88% women (56/64) and the median age was 78 years (range 70-98). 
In the VLP group there were 95% women (55/58) and the median age was 80 years (range 70-
90). The differences were not statistically significant. The dominant hand was injured in 36% 
of the non-operative patients compared with 47% in the VLP group (p = 0.234). The 
distribution of fracture types was similar in both groups. 
PRWE, DASH, grip strength and volar flexion were statistically significantly better for the 
VLP group compared with the non-operative group at three and twelve months (Table 3). The 
differences for PRWE and DASH reached the MCID levels, but grip strength did not (MCID 
for volar flexion was not defined). Most other measurements were equal (Table 3). All 
radiographic measurements were better for the VLP group than for the non-operative group at 
three and twelve months (Table 4).  
There were seven patients (11%) with major complications in the non-operative group 
compared with eight patients (14%) in the VLP group (p=0.606). Three of the non-operatively 
treated patients had a carpal tunnel release, but severe wrist pain persisted and after six months 
a corrective osteotomy was performed. Two patients in the non-operative group were cross-
overs; one developed a severe carpal tunnel syndrome (CTS) the day after initial treatment and 
was treated with carpal tunnel release and VLP fixation, and one had a complete dorsal 
dislocation of the distal fracture fragment and carpus two weeks after initial treatment and was 
then treated with open reduction and VLP fixation. Minor complications occurred in seven 
patients (11%) in the non-operative group compared with eleven patients (20%) in the VLP 
group (p = 0.197). 
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Table 3. Clinical outcomes in patents aged 70 years or older, treated for an unstable dorsally 
displaced DRF with non-operative treatment or VLP fixation 
 
 
All values are presented as means (with standard deviations) and medians (with interquartile ranges) 
*Mann-Whitney U test 
  
 
 
 
Non-operative  
(n=63) 
Volar Locking Plate 
(n=56) 
P-value* 
3 months    
PRWE score 34.2 (21.3), 35.5 (36.8) 20.6 (20.3), 10.3 (29.8) 0.002 
DASH score 30.2 (19.2), 29,2 (31.1) 21.2 (19.3), 14.4 (23.3) 0.016 
EQ-5D score 0.758 (0.200), 0.796 (0.100) 0.805 (0.184), 0.796 (0.280) 0.306 
Extension, degrees 50 (11), 50 (15) 47 (11), 50 (15) 0.111 
Flexion, degrees 46 (15), 45 (23) 57 (15), 60 (20) <0.001 
Supination, degrees 90 (17), 95 (22) 95 (15), 92 (5) 0.485 
Pronation, degrees 82 (11), 82 (16) 86 (8), 90 (5) 0.007 
Ulnar deviation, degrees 24 (6), 24 (8) 25 (7), 25 (10) 0.254 
Radial deviation, degrees 20 (6), 20 (10) 21 (5), 20 (5) 0.371 
Grip strength, % 52.3 (29.3), 53.9 (30.0) 72.4 (18.6), 71.0 (23.0) <0.001 
12 months    
PRWE score 22.4 (21.4), 17.5 (34) 12.7 (15.0), 7.5 (18.3) 0.014 
DASH score 23.1 (19.8), 19.9 (27.5) 15.6 (17.0), 8.3 (24.8) 0.028 
EQ-5D score 0.765 (0.214), 0.796 (0.310) 0.794 (0.240), 0.796 (0.300) 0.215 
Extension, degrees 56 (12), 57 (11) 55 (11), 55 (11) 0.574 
Flexion, degrees 51 (14), 50 (20) 63 (13), 65 (24) <0.001 
Supination, degrees 92 (17), 90 (29) 96 (16), 95 (21) 0.214 
Pronation, degrees 83 (10), 85 (12) 85 (9), 90 (10) 0.126 
Ulnar deviation, degrees 26 (8), 25 (10) 30 (11), 30 (10) 0.030 
Radial deviation, degrees 23 (7), 25 (5) 22 (4), 20 (5) 0.151 
Grip strength, % 80.9 (23.6), 80.0 (22.0)  96.0 (23.7), 96.8 (32.0) 0.001 
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Table 4. Radiographic outcomes in patients aged 70 years or older, treated for an unstable 
dorsally displaced DRF with non-operative treatment or VLP fixation 
 
All values are presented as means (with standard deviations) and medians (with interquartile ranges) 
*Mann-Whitney U-test 
 
  
 
 
Non-operative 
(n=58) 
Volar Locking Plate 
(n=53) 
P-value* 
Dorsal tilt, degrees 
       before treatment 
       after treatment 
       at 3 months 
       at 12 months 
 
27 (8), 27 (9) 
8 (8), 7 (10) 
16 (12), 17(13) 
14 (13), 17 (18) 
 
31 (10), 30 (14) 
-1 (7), -1 (10) 
-3 (8), -5 (11) 
1 (9), 0 (11) 
 
0.019 
<0.001 
<0.001 
<0.001 
Radial inclination, degrees 
       before treatment 
       after treatment 
       at 3 months 
       at 12 months 
 
14 (8), 14 (8) 
18 (6), 19 (7) 
13 (4), 13 (6) 
14 (7), 15(7) 
 
14 (13), 13 (7) 
18 (8), 18 (9) 
20 (6), 19 (9) 
19 (8), 19 (6) 
 
0.901 
0.677 
<0.001 
<0.001 
Radial shortening, mm 
       before treatment 
       after treatment 
       at 3 months 
       at 12 months 
 
2.3 (2.2), 2.3 (4) 
0.6 (1.6), 0.0 (1.7) 
3.0 (2.0), 3.0 (3.3) 
2.7 (2.2), 2.5 (3.0) 
 
2.4 (2.1), 2.0 (3.2) 
0.0 (0.3), 0.0 (0.0) 
0.8 (1.6), 0.0 (0.0) 
0.5 (1.3), 0.0 (1.0) 
 
0.758 
0.007 
<0.001 
<0.001 
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6.4 STUDY IV  
Of the 118 patients evaluated at three years after injury, five who had not completed every EQ-
5D questionnaire were excluded, leaving 113 patients (VLP n = 58, EF n = 55) for the cost-
effectiveness analysis. In the VLP group 88% (51/58) were women and the mean age was 63 
years. In the EF group 96% (53/55) were women and the mean age was also 63 years. The 
dominant hand was injured in 36% (21/58) of the VLP patients compared with 53% (29/55) of 
the EF patients. Differences in baseline characteristics were not statistically significant. The 
distribution of fracture types was similar in both groups. 
During the first year mean direct costs were significantly higher for the VLP group compared 
with the EF group (mean difference (MD) 441 euros, p < 0.001) (Figure 8), mainly driven by 
higher costs for the primary surgery (MD 501 euros, p < 0.001). Most other costs were similar, 
but outpatient care was more expensive for the EF group (MD 93 euros, p = 0.005). Mean 
indirect costs (sick leave) were also higher for the VLP group (MD 436 euros), though not 
statistically significant. The mean total cost at one year was significantly higher for the VLP 
group compared with the EF group (MD 878 euros, p = 0.006).  
At three years the mean difference in direct costs had increased to 554 euros (p < 0.001), mainly 
due to an increase in reoperation costs for VLP patients, from 195 euros during the first year, 
to 287 euros for the entire three-year period. The EF group did not display any more costs for 
reoperations beyond the first year. The mean indirect costs (sick leave) for VLP patients 
increased after the first year, but not for the EF patients, thereby increasing the mean difference 
to 535 euros (p = 0.650) at three years. The mean total cost had increased at three years after 
primary surgery and was 1 089 euros higher (p = 0.012) for the VLP group compared with the 
EF group (Figure 8). 
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Figure 8. Mean costs, one and three years after surgery for patients 50-74 years old, treated 
with EF or VLP fixation due to a DRF. 
 
 
At two and six weeks the VLP group had statistically significantly better mean EQ-5D index 
scores than the EF group, but differences did not remain at later follow-up time points (Figure 
9). The mean total of QALYs during the first year was 0.814 in the VLP group and 0.787 in 
the EF group (p = 0.236) (table 5). After adjustments for baseline (before surgery) differences 
between the groups, the difference in the mean total of QALYs was 0.020 (p = 0.344) in favour 
of the VLP group. At three years, mean total QALYs was 2.6081 in the VLP group and 2.5967 
in the EF group (p = 0.865) and the adjusted mean difference was 0.006 (p = 921) in favour of 
the EF group (table 5). 
 
 
 
EF 1st year VLP 1st year EF 3 years VLP 3 years
Indirect costs 3138 3575 3138 3674
Direct costs 3440 3881 3651 4205
Total costs 6578 7456 6789 7878
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Figure 9. Mean EQ-5D index scores at pre-injury, baseline (before surgery) and follow-up 
points after surgery for patients 50-74 years old, treated with EF or VLP fixation due to a 
DRF. 
 
 
At one year, VLP fixation had an ICER of 31 377 euros per QALY gained compared with EF. 
At three years, the mean total cost was higher for VLP fixation compared with EF, and less 
mean adjusted QALYs were gained, which means that VLP was dominated by EF (Table 5).  
 
Table 5. Cost-effectiveness analysis for VLP fixation compared with EF after DRF surgery 
for patients 50-74 years old. 
 
Costs (euro) 
1st year 
QALYs 1st 
year 
Cost per QALY 
gained 1st year 
Costs (euro) 
3 years 
QALYs at 3 
years 
 
Cost per QALY 
gained at 3 years 
VLP 7 456 0.814 31 377 7 878 2.6081 Dominated 
EF 6 578 0.787  6 789 2.5967  
Difference 878 0.020*  1 089 -0.006*  
*Adjusted for baseline differences 
 
The bootstrap analyses of these estimates are presented in cost-effectiveness planes (Figure 
10). The scatterplots cover all four quadrants indicating uncertainty about whether or not VLP 
was cost-effective and at what value it was cost-effective, compared with EF. The CEACs in 
Figures 11 and 12 summarizes the uncertainty; at a WTP threshold of 35 000 euros, the 
probability of VLP being cost-effective compared with EF was around 50 % at one year and 
40% at three years. Moreover, at three years the probability of VLP being cost-effective 
compared with EF did not exceed 50% independent of the WTP. 
0
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Figure 10. Scatterplots of 1 000 samples of bootstrapped mean total cost and QALY (adjusted 
for baseline differences in EQ-5D index scores) differences over one and three years after VLP 
fixation compared with EF, in cost-effectiveness planes 
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Figure 11. CEAC representing the probability of the cost-effectiveness of treatment using a 
VLP compared with EF at different WTP thresholds at one-year follow-up 
 
 
 
Figure 12. CEAC representing the probability of the cost-effectiveness of treatment using a 
VLP compared with EF different WTP thresholds at three-year follow-up 
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7 DISCUSSION 
 
DRFs are very common, and the incidence of surgical treatment is rising. Moreover, the 
incidence of treatment with VLP is increasing to the detriment of percutaneous methods despite 
the lack of evidence of the superiority of VLP compared with PF or EF. Late complications are 
more common among plated patients, but long-term evaluations are largely lacking. The 
incidence of VLP is also rising among the elderly, but to the detriment of non-operative 
treatment. There are controversies regarding the best treatment for the elderly. From a societal 
perspective it is important that health care providers use cost-effective treatments whenever 
possible. For DRFs, VLP has not been proven to be cost-effective compared with percutaneous 
methods, but studies are few and none has been performed from a perspective of more than one 
year. There is evidence of large regional variation in treatment traditions for DRFs in the US 
and in the Netherlands, but knowledge of similar variations in Sweden is lacking. In regions 
with limited health care resources, knowledge of high incidence of a treatment that is not cost-
effective could be of value. 
The aim of this thesis was to compare treatment outcomes of DRFs; VLP compared with EF 
three years after surgery for patients 50-74 years old regarding functional outcome and cost-
effectiveness, VLP compared with non-operative treatment one year after injury for patients 70 
years or older regarding functional outcome and finally to describe the regional variation in 
treatment regimens in Sweden. 
 
7.1 STUDY I 
Our finding of a large regional variation (adjusted for age and gender) in surgical treatment 
care of DRFs are supported by several authors. Walenkamp et al.127 reported that operative and 
non-operative treatment proportions differed largely among regions in the Netherlands. In the 
US, Fanuele et al.69 and Chung et al.125 found evidence of large regional differences regarding 
surgical treatment methods as well as surgical rates. 
It is possible that some of the variation can be explained by different case mixes, as the register 
data do not include information on fracture classification, but it does not seem likely. Variation 
can also, to some extent, be explained by surgeon specialization – younger age of the surgeon 
and membership in the American Society for Surgery of the Hand (ASSH) are correlated to a 
preference for IF129,139,140. In our study there was no information about the surgeons. However, 
regions including hand surgery clinics did display deviant patterns of surgical treatment rates. 
Plausible explanations for regional variation are personal preferences among surgeons and 
local treatment traditions111,129,141. Regional differences in surgical treatment are common in 
conditions with relative indications for surgery or lack of consistency regarding the best 
surgical option, such as ankle fractures128 and proximal humeral fractures142, and rare in 
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conditions with strict indications for surgery, such as hip fractures129. In the case of DRFs, there 
is a lack of national consensus regarding treatment recommendations, which might be reflected 
by our findings of large regional differences in treatment traditions. 
Other explanations for regional differences may be technology diffusion and financial 
incentives. The more densely populated regions in the south of Sweden had the highest use of 
IF. Also, marketing may influence the choice of treatment when strict guidelines for a 
treatment-decision are lacking. 
To reduce unmotivated variation, treatment decisions regarding DRFs should be based on the 
best available scientific evidence, patient preferences and health economic considerations. 
 
7.2 STUDY II 
7.2.1 PROM results 
Our findings of equivalent results regarding PROMs for VLP and EF three years after surgery 
are supported by several authors. Williksen et al.81 reported similar DASH score for VLP and 
EF after five years, Landgren et al.79 found no difference in DASH scores between plating and 
EF after five years and Kreder et al.143 reported similar Musculoskeletal Functional Assessment 
scores144 for plating and EF after two years. In contrast to our findings, Leung et al.145 reported 
a better Gartland and Werley score for volar or dorsal plating compared with EF after two 
years, but they included only intraarticular fractures and the patients were relatively young 
(mean age = 42 years). Moreover, dorsal plates were routinely removed after six months to 
avoid discomfort due to tendon attrition. 
7.2.2 Reoperations 
When functional results are equivalent, it is important to consider the burden of complications. 
Complications in general are diversely classified in the literature, but reoperation rates are 
commonly reported. In our study there were 21% reoperations for VLP patients compared with 
14% for EF patients after three years. Williksen et al.81 reported 31% reoperations for VLP and 
17% for EF up to five years after primary surgery. Landgren et al.79 reported 54% reoperations 
for plated patients and 41% for EF patients five years after initial surgery. Most of the 
reoperations in our study consisted of plate extractions; 18% of the VLP patients had their plate 
removed and nearly half of the plate removals occurred later than one year after the primary 
surgery. In Williksen and Landgren’s studies mentioned above, they reported 21% and 46% 
plate removals, respectively. Esenwein et al.65 reported plate extraction rates of 35% two years 
after VLP but as they removed plates on patients’ demand they did not consider it as a 
complication.  
Since reoperations occur relatively infrequently, larger studies are needed to detect statistically 
significant differences between groups. A large register study, based on 36 618 patients, found 
significantly more reoperations for plated patients than for EF patients39. For EF patients they 
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occurred early, consisting mainly of secondary plate fixation due to fracture displacement and 
for VLP patients they occurred late, consisting mainly of hardware removal.  
7.2.3 OA 
There were more patients with radiographic signs of OA in the VLP group (42%) compared 
with the EF group (28%). In contrast to our findings, Leung et al.145 reported more OA among 
EF patients than plated patients two years after surgery. Jupiter et al.54 reported radiographic 
signs of OA in 27% of the patients in a cohort of VLP patients. Our results are slightly higher 
which may be due to the fact that we reported OA in both the radiocarpal joint and the distal 
radioulnar (DRU) joint. However, our study was not designed to detect significant differences 
in OA. 
 
7.3 STUDY III 
DASH score, PRWE score and grip strength were clinically significantly better in the VLP 
group compared with the EF group for unstable dorsally displaced DRFs in patients 70 years 
or older three months after injury. Differences remained at one year but did not reach the MCID 
for grip strength. Our findings are supported by Martinez-Mendez et al.117 who reported 
significantly better DASH and PRWE scores for VLP patients compared with non-operatively 
treated patients in a randomized controlled trial (RCT) with 97 patients who were 60 years or 
older with a dorsally displaced intraarticular DRF at two years after injury. In contrast to our 
findings Arora et al.64 reported better DASH and PRWE scores for VLP patients compared 
with non-operatively treated patients in an RCT with 73 patients who were 65 years or older 
with dorsally displaced DRFs, at three months, but not thereafter. Grip strength was statistically 
better for the VLP patients at three and twelve months, but the differences were not clinically 
significant. A multicentre RCT by Bartl et al.113 with 149 patients, 65 years or older, 
randomized to VLP or non-operative treatment for an intraarticular dorsally displaced DRF 
also reported results contradicting our findings. There were no differences in PROMs between 
the groups at any time. However, 42% of the patients in the non-operative group were 
converted to surgical treatment with a VLP within two weeks due to loss of reduction, but were 
still analysed as non-operatives, which probably diminished the differences in outcomes 
between the treatments. In our study there were only two conversions to VLP in the non-
operative group. Therefore, we believe that our findings for the non-operative group represents 
a realistic outcome. 
 
7.4 STUDY IV 
At one year the incremental total cost per gained QALY was just below the threshold 
recommended by NICE. At three years, the mean total cost was higher and less QALYs were 
gained for VLP patients compared with EF patients, indicating that VLP is not cost-effective 
compared with EF. However, the statistical analysis displayed a high level of uncertainty 
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surrounding our estimates, which implies that further studies are needed to support our 
findings. 
To the best of our knowledge there are no previous cost-effectiveness studies comparing VLP 
with EF, but there are some studies comparing VLP with PF. Tubeuf et al.124 found, at one 
year, an incremental cost of 815 euros (converted from UK pounds sterling) for VLP patients 
compared with PF patients. As VLP patients had a smaller gain in QALYs (0.008) than in our 
study, the resulting ICER was higher (100 295 euros per QALY). However, they did not 
investigate patients beyond the first year. Karantana et al.123 presented a study comparing VLP 
with PF and optional EF and reported a statistically significant incremental cost of 801 euros 
(converted from UK pounds sterling) after one year. They also presented a smaller gain in 
QALYs (0.0178) for VLP patients than our study, resulting in an ICER of 44 990 euros per 
QALY for the VLP group in comparison with the PF group. Differences in EQ-5D index scores 
and resulting QALYs were very small in the studies of Tubeuf and Karantana, which is in 
accordance with the findings in our study. Even small differences in total costs render large 
differences in ICER due to small differences in QALYs. It is questionable whether the EQ-5D 
index score is sensitive enough to be used for health economic evaluations in upper extremity 
injuries. No other studies have compared VLP with percutaneous surgical methods for DRFs 
beyond one year and our results indicate that between one and three years after DRF surgery, 
VLP patients increase their costs more than EF patients and EF patients improve their EQ-5D 
index scores more than VLP patients. 
 
7.5 LIMITATIONS AND STRENGTHS  
The major strength of Study I is its size, with a large unselected population of DRF patients 
within a well-defined time-period. The main limitations of Study I are the lack of information 
regarding fracture severity, co-morbidities and surgeon characteristics that could affect 
treatment choices.  
The strengths of Study II are its prospective randomized design, its size and the long follow-
up period. A major limitation is that we had a 12% loss to follow-up from year one to year 
three, and as a consequence we did not reach the sample size from the power estimation.  
The major strength of Study III is that the sample size was large enough to reach statistical 
significance for the primary outcomes. A major limitation is the fusion of two separate studies, 
introducing the risk of bias. However, the study protocols were similar, and an analysis of 
variance did not show any significant differences in outcomes between the two study centres.  
The major strength of Study IV is the long follow-up period as treatment-related costs occur 
after the first year and HRQoL continues to improve. Another strength is the nature of the 
randomized design, which decreased the impact of potential biases. The use of national register 
data enabled us to capture any costs outside the study hospital’s setting. The use of register data 
is also a limitation as we searched for DRG codes and drug prescriptions that we assumed could 
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be associated with the DRF, possibly rendering an overestimation of outpatient visits, sick 
leave and drug usage. Another limitation is that we in the retrospective perspective had to 
estimate the resource use of occupational therapy and X-rays 
.  
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8 CONCLUSIONS 
 
Surgical treatment regimens for DRFs vary widely among health care regions in Sweden and 
when comparing treatment outcomes; for elderly patients VLP fixation seems to yield 
superior clinical results compared with non-operative treatment, but for patients aged 50-74 
years, VLP fixation does not seem to yield superior clinical results and does not seem to be 
cost-effective as compared with EF in a three-year perspective. 
 
Study I: There was a large variation in surgical treatment regimens for DRFs among different 
health care regions in Sweden during the period of 2010 to 2013. Differences were not 
explained by age or gender. Future studies are needed to investigate whether differences in 
fracture pattern exist among regions. There is no support in the literature to motivate the 
differences in treatment traditions that we found. 
Study II: The clinical and radiological results were comparable for VLP fixation and EF three 
years after surgical treatment of patients 50-74 years old with an unstable dorsally displaced 
DRF caused by low-energy trauma. There might be more reoperations after VLP fixation 
compared with EF. This study shows that modern fracture surgery, with more advanced 
technology and a more difficult surgical procedure did not yield a better clinical result than a 
traditional fracture surgery procedure. 
Study III: Contrary to findings described in previous publications, this study showed that VLP 
fixation was superior to non-operative treatment regarding clinical and radiological results for 
patients 70 years or older with an unstable dorsally displaced DRF caused by low-energy 
trauma. The complication rates were similar. The current notion that elderly patients do not 
benefit from fracture surgery of DRFs is challenged by our findings. 
Study IV: VLP fixation of a DRF was not cost-effective compared with EF three years after 
surgical treatment of patients 50-74 years old with an unstable dorsally displaced DRF caused 
by low-energy trauma. However, there was a high level of uncertainty surrounding our 
estimates. The fact that modern fracture surgery methods involve high costs and low gain in 
quality of life compared with traditional methods, represents an important field for future 
evaluation of fracture surgery. 
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9 CLINICAL IMPLICATIONS 
 
Based on the results from the studies conducted for this thesis, it is reasonable to suggest that 
patients aged 50-74 years, who sustain an unstable DRF, should be supplied with full 
information about the different surgical treatment options available including their respective 
advantages and drawbacks. The informed patient should be offered the opportunity to take part 
in treatment decisions in cooperation with the fracture surgeon. From a societal perspective, 
future treatment recommendations should convey the knowledge that percutaneous methods 
are preferred instead of VLP if considered equally suitable for the patient, as VLP does not 
seem to be a cost-effective alternative. National treatment recommendations based on findings 
in the current literature might reduce unmotivated regional differences in treatment traditions. 
Elderly patients, who are living independently and sustain an unstable DRF should be offered 
surgery with VLP as an option to non-operative treatment. Complications to treatment should 
be explained, and if choosing non-operative treatment, patients should be informed about the 
possibility of corrective osteotomy later on. 
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10 FUTURE PERSPECTIVES 
 
There are in general very small differences in the results from the PROMs that we commonly 
use, and the questions in the PROMs do not consider whether the dominant hand is injured or 
not. Clearly, there is a need for a new outcome tool that is more sensitive and can compensate 
for handedness. The outcome tool should be designed to reflect presently performed daily 
activities, such as handling a mobile phone and typing at a computer, and it should also enable 
weighing the questions differently according to the importance for the respondent. 
There is also, in the absence of evidence of the best surgical option, a place for new perspectives 
on how to measure and interpret the current outcomes. To the best of our knowledge, no study 
regarding qualitative matter in fracture surgery has been published. Such information regarding 
patients’ own experiences could add more information for better understanding of this issue. 
The mounting pressure on health care budgets increases the demand for information concerning 
cost-effectiveness of treatment options to avoid allocating resources to treatments that are not 
cost-effective. Therefore, more well-designed health economic evaluations of DRF treatments 
as well as other orthopaedic treatments are needed. Measuring effect in cost-effectiveness 
analyses is challenging as the commonly used EQ-5D index score is possibly not sensitive 
enough to capture small but still clinically important effects regarding upper arm injuries. There 
is need for development of new methods for cost-effectiveness analyses to be able to compare 
DRF treatments. 
A phenomenon discovered during the work for this thesis is that after a DRF, no matter which 
treatment is received, patients restore most of their function, but a small subset of patients have 
much worse results. It is, to our knowledge, unclear why their outcomes are inferior compared 
with the others. To thoroughly investigate this patient group would bring more clarification to 
this issue.  
Finally, national recommendations for treatment of DRFs, based on the best available scientific 
evidence, needs to be developed in Sweden as well as in other countries, to minimize 
unmotivated regional variations and optimize the use of health care resources. 
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11 SAMMANFATTNING PÅ SVENSKA 
 
Handledsfraktur, eller distal radiusfraktur, är den vanligaste frakturen som behandlas inom 
hälso- och sjukvården. Traditionellt har dessa frakturer behandlats med gips om de bedömts 
stabila eller med perkutan kirurgi om de bedömts instabila. Perkutan kirurgi innebär antingen 
temporära stift fästa i skelettet genom huden eller en temporär utanpåliggande extern fixation, 
fäst i skelettet via stift genom huden. Sen 1990-talet, när skelettnära fixation (intern fixation) 
på handledens insida med en så kallad vinkelstabil volar platta introducerades, har incidensen 
för operation av distal radiusfraktur i allmänhet och operation med volar platta i synnerhet ökat 
markant, på bekostnad av gipsbehandling och perkutan kirurgi. Förändringen i 
behandlingspraxis har skett utan att det finns vetenskapliga bevis för att volar platta är bättre 
än perkutan kirurgi för vuxna patienter i allmänhet eller bättre än gipsbehandling för de äldre 
patienterna. Kostnadsstudier från andra länder tyder på att volar platta inte är en 
kostnadseffektiv behandling i jämförelse med perkutana metoder. 
Syftet med denna avhandling var att jämföra patientupplevt behandlingsresultat och 
kostnadseffektivitet mellan behandlingsmetoder samt att beskriva skillnader i förekomst av 
kirurgiska behandlingsmetoder för distala radiusfrakturer mellan olika landsting i Sverige. 
Studie I var en beskrivande studie där data från Svenska Patientregistret användes. 22 378 
vuxna individer var registrerade med en kirurgiskt behandlad distal radiusfraktur mellan åren 
2010 och 2013 i Sverige. Andelen ingrepp med intern fixation var 72% för hela landet. Det 
förelåg stora skillnader i den procentuella fördelningen av de kirurgiska behandlingsmetoderna 
mellan de 21 landstingen. Andelen ingrepp med intern fixation varierade mellan 41% och 95%, 
andelen perkutan stiftning varierade mellan 2% och 44% och andelen extern fixation varierade 
mellan 1% och 19%. Incidensen för kirurgiskt behandlade distal radiusfrakturer varierade 
mellan 4.2 och 9.2 per 10 000 person-år mellan landstingen. 
Studie II och IV bestod av en treårsuppföljning efter en tidigare publicerad randomiserad studie 
av 140 patienter, 50-74 år, med en instabil bakåtvinklad distal radiusfraktur som lottades mellan 
operation med volar platta och extern fixation. 118 patienter deltog i treårsuppföljningen.  I 
Studie II undersöktes patientupplevt behandlingsresultat, greppstyrka, rörelseomfång, 
förekomst av tecken på artros på röntgenbilder samt komplikationer. Det förelåg ingen skillnad 
mellan grupperna. I Studie IV analyserades kostnader och livskvalitetsjusterade levnadsår 
(QALYs) (summan av den patientupplevda hälsorelaterade livskvaliteten upplevd under en 
viss tidsperiod) under de tre första åren efter operationen. Gruppen som behandlats med volar 
platta hade i medeltal högre totalkostnad och lägre QALYs i jämförelse med gruppen som 
behandlats med extern fixation, vilket antyder att volar platta inte är en kostnadseffektiv 
behandling av en instabil bakåtvinklad distal radiusfraktur sett över tre års tid. 
Studie III var en randomiserad studie där 140 patienter, 70 år eller äldre, med en instabil 
bakåtvinklad distal radiusfraktur lottades mellan gipsbehandling och operation med volar 
platta. Efter ett år utvärderades 119 patienter och patientupplevt behandlingsresultat, 
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greppstyrka och röntgenologiskt utseende var signifikant bättre för gruppen som behandlats 
med volar platta. Andelen komplikationer var lika mellan grupperna. 
De viktigaste slutsatserna av denna avhandling är att kirurgiska behandlingsval för distala 
radiusfrakturer skiljer sig stort mellan landstingen i Sverige och gällande jämförelser av 
behandlingsmetoder så verkar operation med volar platta ge ett bättre patientupplevt resultat 
än gipsbehandling för de äldre patienterna, medan för patienter i åldern 50-74 år så verkar 
operation med volar platta inte vare sig ge ett bättre patientupplevt resultat eller vara 
kostnadseffektivt i jämförelse med extern fixation. 
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